Sinorda Biomedicine

China
Haocun, Fujian, China, 550000

Company profile

Sinorda Biomedicine company profile

Sinorda Biomedicine develops medicine and the industrialization of tumor immunotherapy. Their disease treatment program includes anti-tumor sentinel lymph node t-cell therapy, oncolytic virus therapy, tumor-infiltrating t-cell therapy, natural killer cell therapy, dendritic cell therapy, killer t-cell therapy, and tumor immune index monitoring. They also provide immune cell isolation and cryopreservation, accurate genetic testing, and immune function test.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2014-01-01, Year

Headquarters

Postal code
550000
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Last funding
Series A / 2019-11-01
Last equity funding
Series A
Investors
1
Articles
7

Categories and groups

No public categories are available.

Founders and investors

Investors

BUTTON CAPITAL